Amag Pharmaceuticals Supply Agreements
8 Contracts & Agreements
- Supply Agreement, dated as of December 20, 2018, by and between AMAG Pharmaceuticals, Inc. and Ypsomed AG (Filed With SEC on November 1, 2019)
- Commercial Supply Agreement, dated as of June 10, 2016, by and between AMAG Pharmaceuticals, Inc. (as assignee from Palatin Technologies, Inc.) and Catalent Belgium S.A (Filed With SEC on November 1, 2019)
- Product Supply Agreement, dated as of June 1, 2017, by and between AMAG Pharmaceuticals, Inc. and Pfizer, Inc (Filed With SEC on May 8, 2019)
- AMENDED AND RESTATED TECHNICAL TRANSFER AND SUPPLY AGREEMENT by and between PFIZER INC. and AMAG PHARMACEUTICALS, INC. Dated as of December 19, 2016 (Filed With SEC on February 21, 2017)
- AMENDMENT NO. 2 TO PHARMACEUTICAL MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on November 6, 2015)
- AMENDMENT NO. 1 TO PHARMACEUTICAL MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on November 7, 2014)
- SUPPLY AGREEMENT (Filed With SEC on May 5, 2014)
- COMMERCIAL SUPPLY AGREEMENT ACTIVE PHARMACEUTICAL INGREDIENT (Filed With SEC on November 7, 2012)
